title: The V617F mutation of JAK2 is very uncommon in patients with thrombosis.
abstract: Given that many cases of thrombosis do not have a clear cause, a myeloproliferative disease could be involved. We investigated the V617F mutation of the JAK2 gene in 295 patients with thrombosis. Only one case was positive. Therefore, the study of this mutation is not necessary in all patients with idiopathic thrombosis.
authors.forename: Angel F
authors.initials: AF
authors.lastname: Remacha
authors.forename: Camino
authors.initials: C
authors.lastname: Estivill
authors.forename: M Pilar
authors.initials: MP
authors.lastname: Sarda
authors.forename: José
authors.initials: J
authors.lastname: Mateo
authors.forename: Joan Carles
authors.initials: JC
authors.lastname: Souto
authors.forename: Carme
authors.initials: C
authors.lastname: Canals
authors.forename: Josep
authors.initials: J
authors.lastname: Nomdedéu
authors.forename: Jordi
authors.initials: J
authors.lastname: Fontcuberta
mesh_terms: D000368:Aged; D015331:Cohort Studies; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D053614:Janus Kinase 2 / Q000097:blood* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011087:Polycythemia Vera / Q000150:complications / Q000235:genetics; D013920:Thrombocythemia, Essential / Q000150:complications / Q000235:genetics; D013927:Thrombosis / Q000097:blood* / Q000235:genetics*
chemical_list: D006454:Hemoglobins; D053614:Janus Kinase 2